Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous v3.4.1. No study details or user interactions are affected.
    Difference
    0.0%
    Check dated 2026-02-13T13:23:27.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.1, replacing Revision: v3.4.0. This appears to be a minor site update with no changes to study information.
    Difference
    0.0%
    Check dated 2026-02-06T09:12:53.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The label for the update timestamp was changed from 'Last Update Posted (Estimated)' to 'Last Update Posted'. The underlying timestamp value remains the same.
    Difference
    0.0%
    Check dated 2026-01-22T09:34:24.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page update adds a new revision label 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3' label.
    Difference
    0.0%
    Check dated 2026-01-15T04:27:50.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-12-24T14:44:02.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:48:02.000Z thumbnail image

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.